➤ Get the DrugPatentWatch Daily Briefing

Get Daily Updates on Generic Entry, Litigation, Biosimilars, and more …

Serving leading biopharmaceutical companies globally:

McKesson
Colorcon
Harvard Business School
Merck
Johnson and Johnson
Medtronic

Last Updated: September 28, 2020

DrugPatentWatch Database Preview

Patent: 5,314,991

➤ Get the DrugPatentWatch Daily Briefing
» See Plans and Pricing

« Back to Dashboard

Summary for Patent: 5,314,991
Title: Recombinant 40 KDa Dermatophagoides farinae allergen
Abstract:The present invention is directed to a recombinant mite allergen obtainable by expression of a mite-body-derived gene, a gene which codes for said allergen, a mite allergen fragment, a polypeptide having an epitope contained in said allergen, an expression vector capable of expressing the gene, a bacterium, yeast or mammalian cell transformed with said expression vector, a method for producing said allergen, and a pharmaceutical composition or a diagnostic reagent for the treatment of mite allergic diseases.
Inventor(s): Oka; Satoru (Hiroshima, JP), Ono; Kazuhisa (Hiroshima, JP), Shigeta; Seiko (Hiroshima, JP), Wada; Takeshi (Hiroshima, JP)
Assignee: Fumakilla Limited (Tokyo, JP) Hiroshima University (Hiroshima, JP)
Application Number:07/748,783
Patent Claims:see list of patent claims

Details for Patent 5,314,991

Applicant Tradename Biologic Ingredient Dosage Form BLA Number Approval Date Patent No. Assignee Estimated Patent Expiration Status Orphan Source
Greer Laboratories, Inc. STANDARDIZED MITE DERMATOPHAGOIDES FARINAE dermatophagoides farinae CONCENTRATE 101834 1 2010-02-03   Start Trial Fumakilla Limited (Tokyo, JP) Hiroshima University (Hiroshima, JP) 2011-05-24 search
>Applicant >Tradename >Biologic Ingredient >Dosage Form >BLA >Number >Approval Date >Patent No. >Assignee >Estimated Patent Expiration >Status >Orphan >Source

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Express Scripts
Baxter
Medtronic
Mallinckrodt
Boehringer Ingelheim
Harvard Business School

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.